Organization Profile

You just read:

Resverlogix Completes Enrollment of Phase 2 Clinical Trial of RVX-208 in Patients with Pre-Diabetes Mellitus

News provided by

Resverlogix Corp.

Dec 23, 2013, 08:00 ET